Showing results (821-830 of 1,839) with videos related to

Sort By:
Pageof 184
ESMO Open|October 25, 2023
Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysisL Arecco, E Blondeaux, M Bruzzone, et al.
ESMO Open|November 3, 2023
Chronic fatigue in childhood cancer survivors is associated with lifestyle and psychosocial factors; a DCCSS LATER studyA Penson, I Walraven, E Bronkhorst, et al.
ESMO Open|July 6, 2023
Access to novel cancer medicines in four countries in Central and Eastern Europe in relation to clinical benefitT Hofmarcher, P Szilagyiova, A Gustafsson, et al.
ESMO Open|July 2, 2023
A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancerC Chiodoni, S Sangaletti, M Lecchi, et al.
ESMO Open|July 30, 2023
Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors (TKIs) in TKI-untreated EGFR-mutated non-small-cell lung cancer with leptomeningeal metastasesK Tamura, T Yoshida, K Masuda, et al.
ESMO Open|August 25, 2023
Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategiesJ-Y Blay, M von Mehren, R L Jones, et al.
ESMO Open|September 3, 2023
Locoregional radiotherapy improves survival outcomes in de novo metastatic nasopharyngeal carcinoma treated with chemoimmunotherapyY-J Hu, T-Z Lu, H Zhang, et al.
ESMO Open|September 28, 2023
Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?M Aldea, L Friboulet, S Apcher, et al.
ESMO Open|June 4, 2023
S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma-final results of the randomized AIO MATEO phase II trialG Stocker, S Lorenzen, T Ettrich, et al.
ESMO Open|June 1, 2023
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical viewA Natalicchio, M Montagnani, M Gallo, et al.
Pageof 184